Huifeng Zhu

1.3k total citations
39 papers, 999 citations indexed

About

Huifeng Zhu is a scholar working on Molecular Biology, Neurology and Complementary and alternative medicine. According to data from OpenAlex, Huifeng Zhu has authored 39 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Neurology and 8 papers in Complementary and alternative medicine. Recurrent topics in Huifeng Zhu's work include Neurological Disease Mechanisms and Treatments (6 papers), Phytochemistry and Biological Activities (5 papers) and Traditional Chinese Medicine Analysis (4 papers). Huifeng Zhu is often cited by papers focused on Neurological Disease Mechanisms and Treatments (6 papers), Phytochemistry and Biological Activities (5 papers) and Traditional Chinese Medicine Analysis (4 papers). Huifeng Zhu collaborates with scholars based in China, Australia and United States. Huifeng Zhu's co-authors include Dong Wan, Shan Feng, Jinghuan Wang, Mark Willcox, Li Zou, Yanmei Feng, Rui Guo, Ke Liu, Xian Yang and Hongjin Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Huifeng Zhu

38 papers receiving 979 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huifeng Zhu China 18 522 188 125 119 87 39 999
Dewei He China 16 571 1.1× 222 1.2× 75 0.6× 70 0.6× 153 1.8× 26 1.1k
Ying Zong China 18 499 1.0× 115 0.6× 50 0.4× 91 0.8× 100 1.1× 86 1.3k
Hailong Yu China 21 652 1.2× 228 1.2× 93 0.7× 65 0.5× 123 1.4× 58 1.3k
Liyun Shi China 22 519 1.0× 120 0.6× 62 0.5× 82 0.7× 95 1.1× 60 1.2k
Sung Mi Ju South Korea 19 436 0.8× 89 0.5× 170 1.4× 91 0.8× 52 0.6× 22 1.0k
Mohammad Intakhab Alam Saudi Arabia 18 453 0.9× 64 0.3× 56 0.4× 77 0.6× 70 0.8× 52 1.2k
Qamre Alam Saudi Arabia 18 426 0.8× 129 0.7× 50 0.4× 42 0.4× 177 2.0× 51 1.0k
Cheol Min Kim South Korea 25 631 1.2× 78 0.4× 98 0.8× 129 1.1× 172 2.0× 63 1.3k
Hayet Rafa Algeria 13 342 0.7× 150 0.8× 42 0.3× 64 0.5× 133 1.5× 17 881

Countries citing papers authored by Huifeng Zhu

Since Specialization
Citations

This map shows the geographic impact of Huifeng Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huifeng Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huifeng Zhu more than expected).

Fields of papers citing papers by Huifeng Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huifeng Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huifeng Zhu. The network helps show where Huifeng Zhu may publish in the future.

Co-authorship network of co-authors of Huifeng Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Huifeng Zhu. A scholar is included among the top collaborators of Huifeng Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huifeng Zhu. Huifeng Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Meifeng, Si Sun, Yitong Xu, et al.. (2024). Catalpol attenuates ischemic stroke by promoting neurogenesis and angiogenesis via the SDF–1α/CXCR4 pathway. Phytomedicine. 128. 155362–155362. 24 indexed citations
4.
Xu, Jianquan, et al.. (2024). Mixed equilibrium/nonequilibrium effects govern surface mobility in polymer glasses. Proceedings of the National Academy of Sciences. 121(41). e2406262121–e2406262121. 2 indexed citations
5.
Zhu, Huifeng, et al.. (2023). Gastrodin alleviates cisplatin nephrotoxicity by inhibiting ferroptosis via the SIRT1/FOXO3A/GPX4 signaling pathway. Journal of Ethnopharmacology. 319(Pt 3). 117282–117282. 30 indexed citations
6.
Hu, Weiqing, Li Zou, Ningxi Yu, et al.. (2023). Catalpol rescues LPS-induced cognitive impairment via inhibition of NF-Κb-regulated neuroinflammation and up-regulation of TrkB-mediated BDNF secretion in mice. Journal of Ethnopharmacology. 319(Pt 3). 117345–117345. 11 indexed citations
7.
Wang, Jinghui, Yuhua Zhang, Meifeng Zhang, et al.. (2022). Feasibility of Catalpol Intranasal Administration and Its Protective Effect on Acute Cerebral Ischemia in Rats via Anti-Oxidative and Anti-Apoptotic Mechanisms. SHILAP Revista de lepidopterología. 17 indexed citations
8.
Wang, Jinghui, Meifeng Zhang, Si Sun, et al.. (2021). Network Pharmacology-Based Prediction of Catalpol and Mechanisms against Stroke. Evidence-based Complementary and Alternative Medicine. 2021. 1–14. 4 indexed citations
9.
Zhu, Huifeng, et al.. (2020). <p>The Impact of Gut Microbiota Disorders on the Blood–Brain Barrier</p>. Infection and Drug Resistance. Volume 13. 3351–3363. 105 indexed citations
10.
Zhu, Huifeng, et al.. (2019). Catalpol may improve axonal growth via regulating miR-124 regulated PI3K/AKT/mTOR pathway in neurons after ischemia. Annals of Translational Medicine. 7(14). 306–306. 26 indexed citations
11.
Wang, Jinghuan, et al.. (2019). Catalpol induces cell activity to promote axonal regeneration via the PI3K/AKT/mTOR pathway in vivo and in vitro stroke model. Annals of Translational Medicine. 7(23). 756–756. 43 indexed citations
12.
Wan, Dong, et al.. (2019). <p>Staphyloxanthin: a potential target for antivirulence therapy</p>. Infection and Drug Resistance. Volume 12. 2151–2160. 71 indexed citations
13.
Zhu, Huifeng, et al.. (2019). <p>Catalpol Enhances Neurogenesis And Inhibits Apoptosis Of New Neurons Via BDNF, But Not The BDNF/Trkb Pathway</p>. Drug Design Development and Therapy. Volume 13. 4145–4157. 31 indexed citations
14.
Feng, Shan, et al.. (2018). Schisandrin B elicits the Keap1-Nrf2 defense system via carbene reactive metabolite which is less harmful to mice liver. Drug Design Development and Therapy. Volume 12. 4033–4046. 8 indexed citations
16.
Wan, Dong, Xian Yang, Yuan Wang, et al.. (2016). Catalpol stimulates VEGF production via the JAK2/STAT3 pathway to improve angiogenesis in rats’ stroke model. Journal of Ethnopharmacology. 191. 169–179. 72 indexed citations
17.
WATANABE, Keizo, Huifeng Zhu, & Mark Willcox. (2014). Susceptibility of Stenotrophomonas maltophilia Clinical Isolates to Antibiotics and Contact Lens Multipurpose Disinfecting Solutions. Investigative Ophthalmology & Visual Science. 55(12). 8475–8479. 19 indexed citations
18.
Kim, Do Heui, Kumudu Mudiyanselage, János Szanyi, et al.. (2011). Characteristics of Pt–K/MgAl2O4 lean NOx trap catalysts. Catalysis Today. 184(1). 2–7. 25 indexed citations
19.
Zhu, Huifeng, et al.. (2009). [HPLC determination of catalpol in cerebrospinal fluid of rats].. PubMed. 34(13). 1717–9. 4 indexed citations
20.
Yao-nan, Wang, et al.. (2009). Improved adaptive filter based on extremum and mean. Computer Engineering and Applications Journal. 45(32). 180–182. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026